4.4 Article

Novel phosphorylation target in the serum response factor MADS box regulates α-actin transcription

Journal

BIOCHEMISTRY
Volume 42, Issue 24, Pages 7477-7486

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/bi030045n

Keywords

-

Funding

  1. NCI NIH HHS [CA57539] Funding Source: Medline
  2. NHLBI NIH HHS [R01-HL64856, P01-HL49953] Funding Source: Medline
  3. NIAMS NIH HHS [AR19393] Funding Source: Medline

Ask authors/readers for more resources

Serum response factor (SRF) is a phosphoprotein that regulates skeletal and cardiac alpha-actin gene transcription. Myotonic dystrophy protein kinase (DMPK), a muscle- and neuron-restricted kinase, enhanced SRF-mediated promoter activity of the skeletal and cardiac alpha-actin genes in C2C12 myoblasts as well as in nonmyogenic cells. DMPK phosphorylated SRF in vitro in the alphaI coil of the DNA-binding domain in the MADS box, a highly conserved region required for DNA binding, dimerization, and coactivator interaction in COS and CV1 cells. Threonine 159 in the MADS box alphaI coil was a specific phosphorylation target in vitro as well as in vivo of both DMPK and protein kinase C-cc. Substitution of threonine 159 with the nonphosphorylatable residue alanine markedly diminished activation of the cardiac alpha-actin promoter in the presence of kinase, while its substitution with aspartic acid, to introduce a negative charge and mimic phosphorylation, restored activation completely. Phosphorylation of the MADS box may constitute a novel mechanism for regulation of SRF-dependent actin gene transcription.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available